Filing Details
- Accession Number:
- 0001127602-14-013694
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-02 17:14:25
- Reporting Period:
- 2014-03-31
- Filing Date:
- 2014-04-02
- Accepted Time:
- 2014-04-02 17:14:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1585364 | Perrigo Co Plc | PRGO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1267878 | W Todd Kingma | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Executive Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-03-31 | 2,555 | $35.85 | 8,447 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-03-31 | 2,555 | $154.30 | 5,892 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option Right to Buy | Disposition | 2014-03-31 | 2,555 | $0.00 | 2,555 | $35.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,550 | 2018-08-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 3,000 | Indirect | Charitable Remainder Uni-Trust |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 25, 2014. This 10b5-1 plan will expire on the close of business February 25, 2015.
- Exercisable in 3 equal annual installments beginning 8/25/09.
Billionaire Hedge Funds
